Sisätautien klinikka

Julkaisut 2011
Publications 2011

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Abed M et al. Research update for articles published in EJCI in 2009.
2 Airaksinen J. Lapsuusajan ylipainolla vaikutus sydänterveyteen .
3 Airaksinen J. Läppäleikkauksen jälkeinen hoito .
4 Airaksinen J . Apiksabaanikin tehoaa eteisvärinäpotilaan hoidossa .
5 Airaksinen J . Kantasoluista ei ole ainakaan vanhan infarktivaurion korjaajiksi .
6 Airaksinen J . Onko kokonaisvaltaisesta intensiivihoidosta hyötyä tuoreessa tyypin 2 diabeteksessa? .
7 Airaksinen J . Apiksabaani ehdolla eteisvärinäpotilaan hoitoon .
8 Airaksinen J . Aorttaläpän vuoto .
9 Airaksinen J . Kolmoispurjeläpän viat .
10 Airaksinen J . Hiippaläpän prolapsi .
11 Airaksinen J . Hiippaläpän vuodon tutkiminen .
12 Airaksinen J . Hiippaläpän vuodon ennuste ja hoito .
13 Airaksinen J . Hiippaläpän ahtauma .
14 Airaksinen J . Aorttaläpän ahtauman syyt ja merkitys .
15 Airaksinen J . Aorttaläpän ahtauman oireet ja hoito .
16 Airaksinen J . Aorttaläpän vuoto .
17 Airaksinen J , Hippeläinen M . Keuhkovaltimoläpän viat .
18 Airaksinen J , Pietilä M . Sepelvaltimotautipotilaan antitromboottinen hoito.
19 Airaksinen J, Virtanen R. Eteisvärinäpotilaan antokoagulaatiohoito.
20 Airaksinen KEJ et al. Safety of coronary artery bypass surgery during therapeutic oral anticoagulation.
21 Anderson C et al. Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies.
22 ARB Trialists Collarbolation. Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals .
23 Baigent C et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial .
24 Barzilay JI et al. Effects of telmisartan on glucose levels in people at high risk for cardiovascular disease but free from diabetes. The TRANSCEND study.
25 Barzilay JI et al. Albuminuria and decline in cognitive function. The ONTARGET/TRANSCEND Studies.
26 Bernardi L et al. Short-term oxygen administration restores blunted baroreflex sensitivity in patients with type 1 diabetes .
27 Biancari F et al. Postoperative stroke in patients on oral anticoagulation undergoing coronary artery bypass surgery.
28 Bis JC et al. Meta-analysis of genome-wide association studies from the CHARGE consortium identifies common variants associated with carotid intima media thickness and plaque.
29 Bucci M. Lipotoxicity in Obesity and Coronary Artery Disease. Studies by PET, CT and MR.
30 Bucci M et al. Human obesity is characterized by defective fat storage and enhanced muscle fatty acid oxidation, and trimetazidine gradually counteracts these abnormalities .
31 Bucci M et al. Intrapericardial, but not extrapericardial, fat is an independent predictor of impaired hyperemic coronary perfusion in coronary artery disease.
32 Chambers JC et al. Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma.
33 Clase CM et al. Estimated glomerular filtration rate and albuminuria as predictors of outcomes in patients with high cardiovascular risk: a cohort study .
34 Collier DJ et al. Impact of amlodipine-based therapy among older and younger patients in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA) .
35 Collier DJ et al. Impact of atorvastatin among older and younger patients in the Anglo-Scandinavian Cardiac Outcomes Trial Lipid-Lowering Arm .
36 Conde L et al. Novel associations for coronary artery disease derived from genome wide association studies are not associated with increased carotid intima-media thickness, suggesting they do not act via early atherosclerosis or vessel remodeling .
37 Connolly SJ et al. Dronedarone in high-risk permanent atrial fibrillation .
38 Ehret GB et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk .
39 Elovainio M et al. Moderating effect of indoleamine 2,3-dioxygenase (IDO) activation in the association between depressive symptoms and carotid atherosclerosis: Evidence from the Young Finns study.
40 Elovainio M et al. Hostility, metabolic syndrome, inflammation and cardiac control in young adults: The young Finns study .
41 Ferreira MA et al. Identification of IL6R and chromosome 11q13.5 as risk loci for asthma.
42 Forsblom C et al. Serum adiponectin concentration is a positive predictor of all-cause and cardiovascular mortality in type 1 diabetes .
43 Fox ER et al. Association of genetic variation with systolic and diastolic blood pressure among African Americans: the Candidate Gene Association Resource study .
44 Gaemperli O et al. Cardiac hybrid imaging.
45 Gordin D et al. Pulse pressure predicts incident cardiovascular disease but not diabetic nephropathy in patients with type 1 diabetes (The FinnDiane Study) .
46 Gupta AK et al. Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk .
47 Gupta AK et al. Metabolic syndrome, impaired fasting glucose and obesity, as predictors of incident diabetes in 14 120 hypertensive patients of ASCOT-BPLA: comparison of their relative predictability using a novel approach .
48 Haarala A et al. Heart rate variability is independently associated with C-reactive protein but not with serum amyloid A. The Cardiovascular Risk in Young Finns Study.
49 Hankey GJ et al. Effect of clopidogrel plus ASA vs. ASA early after TIA and ischaemic stroke: a substudy of the CHARISMA trial .
50 Hannukainen JC et al. Liver and pancreatic fat content and metabolism in healthy monozygotic twins discordant physical activity .
51 Harjutsalo V et al. Sex-related differences in the long-term risk of microvascular complications by age onset of type 1 diabetes.
52 Harville EW et al. Preconception cardiovascular risk factors and pregnancy outcome.
53 Heinonen I et al. Skeletal muscle blood flow and oxygen uptake at rest and during exercise in humans: a pet study with nitric oxide and cyclooxygenase inhibition .
54 Heiro M et al. Natriumtiosulfaatti - toivoa kalsifylaksian hoitoon .
55 Hewitt S et al. European School of Internal Medicine (ESIM) in Brighton Experiences and reflections .
56 Hirvensalo M et al. Daily steps among Finnish adults: Variation by age, sex, and socioeconomic position.
57 Hirvonen J et al. Effects of insulin on brain glucose metabolism in impaired glucose tolerance .
58 Hori M et al. Efficacy and safety of dabigatran vs. warfarin in patients with atrial fibrillation - Sub-analysis in Japanese population in RE-LY trial - .
59 Huber K et al. Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: Similarities and dissimilarities between North America and Europe .
60 Hänninen MR et al. Determinants of masked hypertension in the general population: the Finn-Home study .
61 Johansson J. Optimal Schedule for Home Blood Pressure Measurements and Clinical Significance of the Variability in Home-Measured Blood Pressure and Heart Rate.
62 Johnsen HE et al. Priming with r-metHuSCF and filgrastim or chemotherapy and filgrastim in patients with malignant lymphomas: a randomized phase II pilot study of mobilization and engraftment.
63 Jolly SS et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial .
64 Juhola J et al. Tracking of serum lipid levels, blood pressure, and body mass index from childhood to adulthood: the Cardiovascular Risk in Young Finns Study.
65 Juonala M et al. The cardiovascular risk in young Finns study and the special Turku coronary risk factor intervention project (STRIP) .
66 Juonala M et al. Childhood environmental and genetic predictors of adulthood obesity: The cardiovascular risk in young Finns study .
67 Juonala M et al. Childhood adiposity, adult adiposity, and cardiovascular risk factors.
68 Juonala M et al. A longitudinal analysis on associations of adiponectin levels with metabolic syndrome and carotid artery intima-media thickness. The cardiovascular risk in young Finns study .
69 Kajander SA et al. Clinical value of absolute quantification of myocardial perfusion with 15 O-water in coronay artery disease .
70 Kalliokoski T et al. Imaging of insulitis in NOD mice with IL-2-Gd-DTPA and 1.5 T MRI.
71 Karjalainen PP et al. Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stent implantation in a real-world population: A comparison with paclitaxel-eluting: The PORI registry.
72 Kauhanen S et al. Complementary roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in medullary thyroid cancer.
73 Kemppainen J et al. Reversible brain hypometabolism associated with central nervous system systemic lupus erythematosus.
74 Kilpeläinen TO et al. Physical activity attenuates the influence of FTO variants on obesity risk: A meta-analysis of 218,166 adults and 19,268 children.
75 Kivimäki M et al. Conventional and Mendelian randomization analyses suggest no association between lipoprotein(a) and early atherosclerosis: the young Finns study .
76 Kiviniemi TO et al. Cold pressor test safety - The incidence of vasovagal reactions .
77 Knuuti J , Saraste A . Hybrid SPECT-CT and PET-CT: Current concepts and development .
78 Kohonen I et al. Computed Tomography of Osteolysis Related to Total Ankle Replacement.
79 Koistinen J , Pakarinen S . Mitä sydämen tahdistinhoito on tänään? .
80 Koivistoinen T et al. Metabolic syndrome in childhood and increased arterial stiffness in adulthood - The Cardiovascular Risk in Young Finns Study.
81 Koivistoinen T et al. Apolipoprotein B is related to arterial pulse wave velocity in young adults: the Cardiovascular Risk in Young Finns Study.
82 Koivuviita N . Vascular Function in Chronic Kidney Disease and in Renovascular Disease .
83 Koivuviita N et al. The effect of revascularization of atherosclerotic renal artery stenosis on coronary flow reserve and peripheral endothelial function .
84 Korhonen PE et al. Health-related quality of life and awareness of hypertension .
85 Korpela S et al. Myosiitit.
86 Koskinen J. Metabolic Syndrome. Early Cardio-Metabolic, Vascular and Hepatic changes. The Cardiovascular Risk in Young Finns Study.
87 Koskinen T et al. Relations between carotid artery distensibility and heart rate variability. The Cardiovascular Risk in Young Finns study.
88 Krum H et al. Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE study .
89 Kytö JP et al. Decline in the cumulative incidence of severe diabetic retinopathy in patients with type 1 diabetes .
90 Lahdenne P et al. Kuka pelkää punkkia? .
91 Lakkisto P et al. Heme oxygenase-1 induction protects the heart and modulates cellular and extracellular remodelling after myocardial infarction in rats .
92 Lammintausta A et al. Myocardial infarction events and cardiovascular risk factor levels in Finnish- and Swedish-speaking populations in Finland.
93 Lamy A et al. The cost implications of the use of telmisartan or ramipril in patients at high risk for vascular events: the ONTARGET study.
94 Lassenius MI et al. Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation .
95 Lehto H-R et al. Sex differences in short- and long-term case-fatality of myocardial infarction .
96 Lehto M et al. Eteisvärinän hoito Suomessa - FinFib-tutkimus .
97 Lehtonen H-M et al. Different berries and berry fractions have various but slightly positive effects on the associated variables of metabolic diseases on overweight and obese women .
98 Lehtopolku M et al. Ribosomal mutations as the main cause of macrolide resistance in Campylobacter jejuni and Campylobacter coli.
99 Leino KA et al. The effect of body mass index on the spread of spinal block in patients with rheumatoid arthritis .
100 Leinonen V-M et al. Low-dose acetylsalicylic acid and blood pressure control in drug-treated hypertensive patients .
101 Levy GV et al. Antibodies against the Trypanosoma cruzi ribosomal P proteins induce apoptosis in HL-1 cardiac cells .
102 Lindroos MM et al. Mitochondrial diabetes is associated with insulin resistance in subcutaneous adipose tissue but not with increased liver fat content.
103 Linko R et al. Serum zinc in critically ill adult patients with acute respiratory failure.
104 Lithovius R et al. Cumulative cost of prescription medication in outpatients with type 1 diabetes in Finland .
105 Magnussen CG et al. Use of B-mode ultrasound to examine preclinical markers of atherosclerosis: image quality may bias associations between adiposity and measures of vascular structure and function .
106 Mahaffey KW et al. Ticagrelor compared with clopidogrel by geographic region in the platelet inhibition and patient outcomes (PLATO) trial .
107 Malmberg M et al. Cardiomyocyte apoptosis after cardioplegic ischemia: Comparison to unprotected regional ischemia-reperfusion.
108 Merjonen P et al. Breastfeeding and offspring hostility in adulthood .
109 Mielniczuk LM et al. Relation between right ventricular function and increased right ventricular [18F] fluorodeooxyglucose accumulation in patients with heart failure .
110 Miettinen JA et al. Effects of intracoronary injection of autologous bone marrow-derived stem cells on natriuretic peptides and inflammatory markers in patients with acute ST-elevation myocardial infraction .
111 Mustila A et al. Anti-citrullinated peptide antibodies and the progression of radiographic joint erosions in patients with early rheumatoid arthritis treated with the FIN-RACo combination and single disease-modifying antirheumatic drug strategies .
112 Nekolla SG , Saraste A . Novel F-18-Labeled PET myocardial perfusion tracers: Bench to bedside .
113 Neldam S et al. Telmisartan and amlodipine single-pill combinations vs amlodipine monotherapy for superior blood pressure lowering and improved tolerability in patients with uncontrolled hypertension: results of the TEAMSTA-5 study .
114 Niemelä M et al. Randomized comparison of final kissing balloon dilatation versus no final kissing balloon dilatation in patients with coronary bifurcation lesions treated with main vessel stenting.
115 Niiranen TJ et al. Optimal schedule for home blood pressure measurement based on prognostic data .
116 Nuutinen H et al. Pulmallinen vatsavaiva, askites ja pleuraneste .
117 Ohlsson C et al. Genetic determinants of serum testosterone concentrations in men.
118 Oikonen M et al. Genetic variants and blood pressure in a population-based cohort: the Cardiovascular Risk in Young Finns Study.
119 Okin PM et al. Serial assessment of the electrocardiographic strain pattern for prediction of new-onset heart failure during antihypertensive treatment: the LIFE study .
120 Okkonen M et al. N-terminal-pro-BNP in critically ill patients with acute respiratory failure: a prospective cohort study .
121 Oksi J. Totta ja tarua borrelioosista .
122 Oldgren J et al. Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial .
123 Orava J et al. Different metabolic responses of human brown adipose tissue to activation by cold and insulin .
124 Pahkala K et al. Association of physical activity with vascular endothelial function and intima-media thickness.
125 Patel MR et al. Cardiovascular events in patients with Fabry disease .
126 Paterson DI et al. Recent advances in cardiac imaging for patients with heart failure .
127 Pouleur A-C et al. Suppression of aldosterone mediates regression of left ventricular hypertrophy in patients with hypertension .
128 Pulkki-Råback L et al. Adulthood EAS-temperament and carotid artery intima-media thickness: the Cardiovascular Risk in Young Finns study .
129 Putkonen M. Autologous Stem Cell Transplantation in Multiple Myeloma .
130 Raatikainen P et al. Eteisvärinä .
131 Raggi P et al. The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis .
132 Rahman S et al. Associations of cardiovascular risk factors, carotid intima-media thickness and manifest atherosclerotic vascular disease with carpal tunnel syndrome .
133 Raiko J. Conventional and Novel Cardiovascular Risk Factors in Young Finns and Their Associations with Structural and Functional Vascular Changes of Subclinical Atherosclerosis. The Cardiovascular Risk in Young Finns Study.
134 Rantalaiho V et al. Trends in treatment strategies and usage of different disease-modifying anti-rheumatic drugs in early rheumatoid arthritis in Finland. Results from a nationwide register in 2000-2007.
135 Rantanen I, Tuominen R. Relative magnitude of presenteeism and work-related factors affecting them among health care professionals .
136 Rosengård-Bärlund M et al. Baroreflex sensitivity and its response to deep breathing predict increase in blood pressure in type 1 diabetes in a 5-year follow-up .
137 Rosenström T et al. Change in job strain and progression of atherosclerosis: The Cardiovascular Risk in Young Finns study .
138 Rönnemaa T. Valtimoverenkierron häiriöt jaloissa diabeetikolla .
139 Rönnemaa T. Neuropatian ehkäisy ja hoito .
140 Rönnemaa T. Diabetekseen liittyvät yläraajaongelmat .
141 Rönnemaa T . Jatkuva verensokerimittaus .
142 Rönnemaa T . Minimed -glukoosisensori .
143 Rönnemaa T . Jatkuvanäyttöiset glukoosisensorit .
144 Rönnemaa T . Liikunta tyypin 2 diabeteksessa .
145 Rönnemaa T . Jalkojen omaseuranta .
146 Rönnemaa T . Jalkojen omahoito .
147 Rönnemaa T . Kenkien ja sukkien valinta .
148 Rönnemaa T . Mistä diabeetikon jalkaongelmat johtuvat? .
149 Rönnemaa T . Diabeetikon jalkaongleman laukaisevat tekijät .
150 Rönnemaa T . Neuropatiasta johtuvat haavaumat.
151 Rönnemaa T . Charcot´n jalka eli neuroartropatia .
152 Rönnemaa T . Diabeetikon jalkavaurioiden jälkihoito .
153 Rönnemaa T . Miten, miksi ja milloin munuaisten toiminta voi häiriintyä? .
154 Rönnemaa T . Miten munuaisten toimintaa tutkitaan? .
155 Rönnemaa T . Nefropatian oireet .
156 Rönnemaa T . Nefropatian ehkäisy .
157 Rönnemaa T . Nefropatian hoito .
158 Rönnemaa T . Muut munuaisongelmat .
159 Rönnemaa T . Mitä on neuropatia?
160 Rönnemaa T . Neuropatiaoireet .
161 Rönnemaa T . Neuropatian tutkiminen .
162 Rönnemaa T . Diabetes ja iho .
163 Rönnemaa T . Erektiohäiriöt ja diabetes.
164 Rönnemaa T . Miten ja miksi diabeteksen lisäsairauksia voi kehittyä?
165 Rönnemaa T . Kohonnut verenpaine ja sen lääkehoito diabeetikolla .
166 Rönnemaa T . Kolesteroli- ja triglyseridiaineenvaihdunnan häiriöt ja niiden hoito diabeetikolla .
167 Rönnemaa T . Lisääntynyt hyytymistaipumus ja diabetes .
168 Rönnemaa T . Miksi diabeetikon sepelvaltimotautiriski on muita suurempi?
169 Rönnemaa T . Sepelvaltimotaudin oireet ja tutkimukset diabeetikolla .
170 Rönnemaa T . Sepelvaltimotaudin ehkäisy ja hoito .
171 Rönnemaa T . Sepelvaltimokohtaus (sydäninfarkti) ja diabetes .
172 Rönnemaa T . Aivoverenkiertohäiriöt ja diabetes .
173 Rönnemaa T . Näköhäiriöt diabeteksen toteamisvaiheessa .
174 Rönnemaa T . Osteoporoosi ja diabetes .
175 Rönnemaa T . Diabetes ja kilpirauhanen .
176 Rönnemaa T . Diabetes ja keliakia .
177 Rönnemaa T . Diabetes ja syöpä .
178 Rönnemaa T . Diabeetikko leikkauksissa ja erityistutkimuksissa .
179 Rönnemaa T . Diabetes ja rokotukset .
180 Rönnemaa T . Työelämää koskevia järjestelyitä esimerkkien valossa .
181 Rönnemaa T , Huhtanen J. Lievien jalkaongelmien hoito .
182 Rönnemaa T , Leppiniemi E. Verensokerin omaseuranta.
183 Rönnemaa T , Summanen P. Retinopatian ehkäisy .
184 Rönnemaa T , Summanen P . Harmaakaihi ja diabetes .
185 Rönnemaa T, Summanen P. Retinopatian hoito .
186 Rönnemaa T, Summanen P . Mitä tapahtuu verkkokalvosairaudesssa eli retinopatiassa? .
187 Saraheimo M , Rönnemaa T . Pitkään diabetesta sairastaneen vanheneminen .
188 Saraheimo M , Rönnemaa T . Vanhuusiässä diabetekseen sairastuvan hoitotavoitteet .
189 Saraheimo M , Rönnemaa T . Vanhuusiässä diabetekseen sairastuneen verensokerin seuranta .
190 Saraheimo M , Rönnemaa T . Lisäsairauksien ehkäisy vanhuusiässä tyypin 2 diabetekseen sairastuneilla .
191 Saraheimo M , Rönnemaa T . Korkean verensokerin aiheuttama tajuttomuus ilman happomyrkytystä .
192 Saraheimo M, Rönnemaa T . Vanhuusiässä tyypin 2 diabetekseen sairastuneen sokeritasapainon hoito .
193 Schlesinger J et al. Isomerism of [64Cu-NOTA-Bn]-labeled radiotracers: Separation of two complex isomers and determination of their interconversion energy barrier using ion pair chromatography.
194 Schmieder RE et al. Changes in albuminuria predict mortality and morbidity im patients with vascular disease .
195 Scirica BM et al. The incidence of bradyarrhythmias and clinical bradyarrhytmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) Trial .
196 Sherif HM et al. Simplified quantification of myocardial flow reserve with flurpiridaz F 18: Validation with microspheres in a pig model .
197 Silvola JMU et al. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
198 Silvola JMU et al. Detection of hypoxia by [18F]EF5 in atheroschlerosis plaques in mice .
199 Simonsson B et al. Combination of pegylated IFN-alfa2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia.
200 Skilton MR et al. Fetal growth and preterm birth influence cardiovascular risk factors and arterial health in young adults: the Cardiovascular Risk in Young Finns Study.
201 Speliotes EK et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits .
202 Stenholm T et al. Evaluation of the TPX MRSA assay for the detection of methicillin-resistant Staphylococcus aureus .
203 Stone GW et al. A prospective, randomized evaluation of a novel everolimus-eluting coronary stent .
204 Stranges S et al. Selenium status and blood lipids: the cardiovascular risk in young finns study.
205 Strawbridge RJ et al. Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes.
206 Sundell J . Lihasvoimaharjoittelu on liian vähän käytetty täsmälääke lihavuudessa ja vanhuudessa .
207 Sundell J . Voiko ravintolisillä edistää terveyttä?
208 Sundell J . Avosydänleikkauksen jälkeinen sternaalipunktio .
209 Sundell J . Resistance training is an effective tool against metabolic and frailty syndromes .
210 Sundell J et al. Increased B-type natriuretic peptide concentration is associated with reduced coronary vasoreactivity in patients with dilated cardiomyopathy but not in healthy young subjects .
211 Sundell J et al. Heraproteiini ja kreatiini urheiluravintolisinä .
212 Sundell J, Salospohja T. Kuntosaliharrastajat ja doping - lääkärin vastaanotolla .
213 Surakka I et al. A genome-wide screen for interactions reveals a new locus on 4p15 modifying the effect of waist-to-hip ratio on total cholesterol.
214 Syreeni A et al. Genetic examination of SETD7 and SUV39H1/H2 methyltransferases and the risk of diabetes complications in patients with type 1 diabetes .
215 Talvia S et al. Parental eating attitudes and indicators of healthy eating in a longitudinal randomized dietary intervention trial (the STRIP study).
216 Tardif J-C et al. Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy.
217 Tenovuo J , Rönnemaa T . Diabetes ja suu .
218 Tertti K et al. Transfer of repaglinide in the dually perfused human placenta and role of organic anion transporting polypeptides (OATPs).
219 Thomas MC et al. Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes .
220 Tikkanen E et al. Association of known Loci with lipid levels among children and prediction of dyslipidemia in adults .
221 Tobe SW et al. Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk. Results from the ONTARGET and TRANSCEND studies .
222 Tolonen S et al. Lactase gene C/T -13910 polymorphism, calcium intake, and pQCT bone traits in Finnish adults .
223 Tolonen S et al. Association of apolipoprotein E promoter polymorphisms with bone structural traits is modified by dietary saturated fat intake - The Cardiovascular Risk in Young Finns Study .
224 Tuominen R et al. Willingness to pay for improvement of physical function among rheumatoid arthritis patients as measured by Health Assessment Questionnaire.
225 Tuominen R et al. How much is a reduction in morning stiffness worth to patients with rheumatoid arthritis?
226 Tuunanen H, Knuuti J. Metabolic remodelling in human heart failure.
227 Varis A et al. Keskushermostoinfektio - puutiaisaivokuume, neuroborrelioosi vai molemmat? .
228 Varis J et al. Sinisten varpaiden oireyhtymä - antikoagulanttihoidon harvinainen komplikaatio .
229 Varis J et al. Both hypertensive men and women are inadequately treated in Finnish general practice .
230 Vepsäläinen T et al. Physical activity, high-sensitivity C-reactive protein, and total and cardiovascular disease mortality in type 2 diabetes .
231 Verbeke F et al. Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: Outcome of the calcification outcome in renal disease (CORD) study.
232 Vesanen M . Vaikeaa A-hemotofiliaa sairastavat hyötyvät verenvuotoja ehkäisevästä hoidosta .
233 Vesanen M . Uusien antikoagulanttien tiellä ei hidasteita .
234 Vesanen M . Vähempikin riittää leukemian ensihoidossa .
235 Vesanen M . Myelodysplastinen oireyhtymä avautuu hieman.
236 Vesanen M . Trombosyyttien nostoon uusi vaihtoehto .
237 Vihinen T et al. Knock knock knocking on: how to open stuck mitral valve prosthesis .
238 Virkki LM et al. Outcomes of switching anti-TNF drugs in rheumatoid arthritis- A study based on observational data from Finnish Register of Biological Treatment (ROB-FIN).
239 Virtanen KA, Nuutila P. Brown adipose tissue in humans.
240 Virtanen M et al. Patients with infectious deseases, overcrowding, and health in hospital staff.
241 Virtanen S et al. Voxelwise analysis of diffusion tensor imaging and structural MR imaging in patients with the m.3243A>G mutation in mitochondrial DNA.
242 Vähäsilta T et al. Cardiomyocyte apoptosis following antegrade and retrograde cardioplegia during aortic valve surgery.
243 Wain LV et al. Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure.
244 Weber M et al. High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: a substudy from CHARISMA trial.
245 Wendelin-Saarenhovi M et al. Plasma osteopontin is not associated with vascular markers of subclinical atherosclerosis in a population of young adults without symptoms of cardiovascular disease. The Cardiovascular Risk in Young Finns Study.
246 Wessman M et al. Novel susceptibility locus at 22q11 for diabetic nephropathy in type 1 diabetes .
247 Würtz P et al. Characterization of systemic metabolic phenotypes associated with subclinical atherosclerosis.
Julkaisutietokanta 23.11.2012 Publications Data Base 23.11.2012